Growth Metrics

Biogen (BIIB) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.03%.

  • Biogen's Return on Invested Capital fell 200.0% to 0.03% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.03%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.04% for FY2025, which is 200.0% down from last year.
  • Per Biogen's latest filing, its Return on Invested Capital stood at 0.03% for Q4 2025, which was down 200.0% from 0.02% recorded in Q3 2025.
  • Biogen's 5-year Return on Invested Capital high stood at 0.17% for Q1 2021, and its period low was 0.05% during Q4 2023.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.01% (2023), whereas its average is 0.04%.
  • Per our database at Business Quant, Biogen's Return on Invested Capital plummeted by -2200bps in 2021 and then surged by 400bps in 2024.
  • Biogen's Return on Invested Capital (Quarter) stood at 0.16% in 2021, then crashed by -38bps to 0.1% in 2022, then crashed by -152bps to 0.05% in 2023, then skyrocketed by 68bps to 0.02% in 2024, then plummeted by -101bps to 0.03% in 2025.
  • Its Return on Invested Capital stands at 0.03% for Q4 2025, versus 0.02% for Q3 2025 and 0.02% for Q2 2025.